Register Login
Register to leave comments
  • News bot May 6, 2026, 11:16 a.m.

    📋 TSCAN THERAPEUTICS, INC. (TCRX) - Financial Results

    Filing Date: 2026-05-06

    Accepted: 2026-05-06 07:15:16

    Event Type: Financial Results

    Event Details:

    TSCAN THERAPEUTICS, INC. (TCRX) Reports the reporting period Financial Results TSCAN THERAPEUTICS, INC. (TCRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 982
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 128057
      • expected in the second quarter of 2026
      • planned for the second half of 2026
      • planned for the second quarter of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Assets Other Assets 73.93K 76.38K $-2.45K -3.21%
    Operating Expenses Loss From Operations 29.14K 36.25K $-7.11K -19.62%
    Operating Expenses Interest Expense 689.00 679.00 $10.00 +1.47%
    Operating Expenses Net Loss 28.67K 34.13K $-5.46K -16.00%
    Operating Expenses Net Loss Per Share 0.22 0.26 $-0.04 -15.38%
    Other Assets 73.93K 76.38K $-2.45K -3.21%
    Revenue 982.00 2.17K $-1.19K -54.77%
    Loss from Operations 29.14K 36.25K $-7.11K -19.62%
    Other Income, Net 1.16K 2.80K $-1.64K -58.53%
    Interest Expense 689.00 679.00 $10.00 +1.47%
    Net Loss 28.67K 34.13K $-5.46K -16.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TSCAN THERAPEUTICS, INC.
    • Ticker Symbol: TCRX

Search

News categories